OMAIDA C VELAZQUEZ, MD
Radiology at 12 Ave, Miami, FL
License number
Florida ME100087
Category
Radiology
Type
Vascular Surgery
License number
Florida MD054213L
Category
Radiology
Type
Vascular Surgery
Address
Address
1611 NW 12Th Ave FL CTR4, Miami, FL 33136
Phone
(305) 585-6000
(305) 585-8569 (Fax)
(305) 585-8569 (Fax)
Organization information
See more information about OMAIDA C VELAZQUEZ at bizstanding.comOmaida C Velazquez MD
1295 NW 14 St STE J, Miami, FL 33125
Categories:
Physicians & Surgeons
Phone:
(305) 585-5284 (Phone)
Professional information
Omaida Caridad Velazquez, Miami FL
Specialties:
Surgery, Vascular Surgery, General Practice
Work:
Jackson Memorial Hospital
1611 NW 12Th Ave, Miami, FL 33136 Sylvester Comprehensive Cancer Center
1475 NW 12Th Ave, Miami, FL 33136 Miami Va Healthcare System
1201 NW 16Th St, Miami, FL 33125 University of Miami Hospital
1295 NW 14Th St, Miami, FL 33125
1611 NW 12Th Ave, Miami, FL 33136 Sylvester Comprehensive Cancer Center
1475 NW 12Th Ave, Miami, FL 33136 Miami Va Healthcare System
1201 NW 16Th St, Miami, FL 33125 University of Miami Hospital
1295 NW 14Th St, Miami, FL 33125
Education:
UMDNJ (1991) Vascular Surgery
Md At University Of Miami
Location:
Miami/Fort Lauderdale Area
Industry:
Higher Education
Compositions, Kits, And Methods For Promoting Ischemic And Diabetic Wound Healing
US Patent:
2012005, Mar 8, 2012
Filed:
Apr 9, 2010
Appl. No.:
13/138889
Inventors:
Omaida C. Velazquez - Miami FL, US
International Classification:
A61K 38/19, A61P 17/02, A61K 33/00, A61K 35/76, A61K 48/00, A61K 38/17
US Classification:
424 932, 514 44 R, 514 186, 514 94, 424613
Abstract:
Compositions, kits and methods for promoting diabetic wound healing are based on the discovery that SDF-1α specifically upregulates expression of E-selectin in mature endothelial cells (EC), leading to an increase in EC-endothelial progenitor cell (EPC) adhesion and EPC homing. Methods for promoting healing of a wound in a diabetic subject include providing a therapeutically effective amount of a composition including E-selectin protein or a nucleic acid encoding E-selectin protein, and optionally, an agent that specifically upregulates E-selectin expression (e.g., SDF-1α). The methods can also include administering hyperbaric oxygen treatment to the subject. Administering the composition to the subject results in migration of bone marrow-derived progenitor cells to the wound, accelerated wound healing, and upregulation of E-selectin expression in the subject.
Pancreatic Islet Cells Composition And Methods
US Patent:
2010027, Oct 28, 2010
Filed:
Apr 10, 2008
Appl. No.:
12/595411
Inventors:
Ali Naji - North Wales PA, US
Ming Yu - Wallingford PA, US
Chengyang Liu - Philidelphia PA, US
Omaida C. Velazquez - Miami FL, US
Ming Yu - Wallingford PA, US
Chengyang Liu - Philidelphia PA, US
Omaida C. Velazquez - Miami FL, US
International Classification:
A61K 35/39, A61P 3/10
US Classification:
424 9321, 424 937
Abstract:
A composition comprising islet cells and an extracellular matrix component as well as methods of transplanting same are described. Retroperitoneal and subcutaneous islet cells transplants maintain their viability and increased insulin production for prolonged periods of time.